Description
Pre-filled syringe with sodium salt hyaluronic acid solution for peritendinous use. Hyalotend consists of a viscous solution of hyaluronic acid sodium salt (500-730 kDa) obtained by bacterial fermentation, in buffered physiological solution, for peritendinous injection.The solution (20 mg / 2 ml) is contained in a pre-filled syringe and is supplied sterile . Hyaluronic acid is a major component of synovial fluid, is produced in the normal tendon sheath and is a major component of the tendon's extracellular matrix. The administration of the sodium salt of exogenous hyaluronic acid in the peritendinous space, thanks to its viscoelastic properties, reduces the superficial friction of the tendons, increases the sliding capacity, reduces pain and improves tendon function in endinopathy, thus accelerating the return to normal activities and allosport. Hyalotend is indicated for the treatment of pain and the improvement of tendon elasticity in tendinopathy of the upper and lower limbs.

Composition
Hyaluronic acid sodium salt, sodium chloride, sodium phosphatebasic dodecahydrate, monobasic sodium phosphate dihydrate, water for injectable preparations.

How to use
The administration of the product must be carried out exclusively by expert medical personnel. Administer with an ultrasound probe to guide the injection if necessary. All the rules concerning the aseptic administration technique must be strictly followed. Do not use concomitantly with disinfectants containing quaternary ammonium salts, as hyaluronic acid can precipitate in their presence. Use a suitable sterile needle (21-25 G) according to medical advice. Discard the syringe and needle after single use.
Administer 3 peritendin injections of the product at weekly intervals, according to medical advice. If necessary more tendons can be treated simultaneously. Each syringe is intended for the injection of a single tendon. Repeated treatments can be performed if required.

Warnings
Hyalotend should not be administered to patients with known hypersensitivity to any component of the product. Peritendin injections of Hyalotend are contraindicated in case of skin infections or diseases in the area of the injection site. Hyalotend has not been tested in pregnant women or individuals below 18 years of age and is therefore contraindicated in these patient populations. Do not use the product after the expiry date shown on the package. Do not use the product if the package is open or damaged: the sterility of the solution is guaranteed as long as the package is closed and intact. The syringe is for single use only, which means that it should only be used for one injection. The assembled syringe should be discarded immediately after use, regardless of whether the solution has been fully administered or not. If a syringe is used for a subsequent injection, there is a risk of contamination which could lead to illness, infection and / or serious harm to the patient. If the product is reprocessed and / or reused, FidiaFarmaceutici cannot guarantee its performance, functionality, material structure, cleanliness or sterility. Reprocessing and / or reuse can cause serious harm to patient health and safety. After use, dispose of according to current regulations. As with any joint invasive procedure, care is recommended not to overload the joint immediately after peritendinous injection. Keep out of the reach of children. Potrebber